• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

safest adhd medication for adults Medication During Pregnancy and Breastfeeding

Women with ADHD have to make a difficult choice regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. Little data exists about how long-term exposure to these medications may affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues like hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge that further high-quality studies are needed.

Risk/Benefit Analysis

Pregnant women who take adhd medication and pregnancy uk (mouse click the up coming article) medications must weigh the advantages of taking them against the potential risks to the foetus. Physicians don't have the information needed to provide clear recommendations but they can provide information on risks and benefits that aid pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during early pregnancy were not at a greater risk of fetal malformations or structural birth defects. Researchers conducted a large population-based case-control study to assess the risk of major structural birth defects in infants born to mothers who had taken stimulants in the early stages of pregnancy, as well as those who had not. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to confirm that the classification was accurate and to eliminate any bias.

The research conducted by the researchers was not without limitations. Researchers were unable in the beginning to differentiate the effects caused by the medication from the disorder. This limitation makes it difficult for researchers to determine if the few associations observed between the exposed groups were due to the use of medication or caused by comorbidities. In addition the study did not examine the long-term effects of offspring on their parents.

The study did reveal that infants whose mothers took ADHD medications during pregnancy were at slightly more risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or cut back on their medications prior to or during pregnancy. This was due to central nervous system disorders. The higher risk of admission was not affected by the stimulant medication used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy also had an elevated chance of having a caesarean delivery or having a baby with a low Apgar score (less than 7). These increases appeared to be independent of the type of medication used during pregnancy.

Researchers suggest that the small risk of using ADHD medication for adhd and anxiety during pregnancies in the early stages can be offset by greater benefits for baby and mother of continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, where they are able, assist them in developing strategies to improve coping skills that may minimize the negative impact of her condition on her daily life and relationships.

Medication Interactions

As more women than ever before are being diagnosed with ADHD and being treated with medication, the question of whether to keep or end treatment during pregnancy is a question that doctors are having to face. These decisions are often made without clear and reliable evidence. Instead, doctors have to consider their own expertise, the experience of other physicians and the research on the topic.

Particularly, the subject of potential risks to the baby can be a challenge. The research that has been conducted on this topic is based on observations rather than controlled studies, and the results are in conflict. Most studies focus on live-births, which could underestimate the teratogenic impact that can lead to abortions or terminations of pregnancy. The study presented in this journal club addresses these issues by looking at data from both live and deceased births.

Conclusion A few studies have found an association between ADHD medications and certain birth defects, other studies have not established a link. Most studies have shown a neutral, or even slight negative effect. In each case an in-depth analysis of the potential risks and benefits is required.

For a lot of women with ADHD, the decision to stop medication can be difficult, if not impossible. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of isolation. A decrease in medication could also affect the ability to safely drive and complete work-related tasks, which are essential aspects of everyday life for those suffering from ADHD.

She suggests that women who are unsure whether to continue taking the medication or stop due to pregnancy should educate family members, colleagues, and their friends about the condition, its impact on daily functioning and the benefits of continuing the current treatment. It can also help a woman feel more confident in her decision. Certain medications can be passed through the placenta. If a woman decides not to take her ADHD medication while breastfeeding, it is important to be aware that the drug could be transferred to the baby.

Risk of Birth Defects

As the use and abuse of ADHD medications to treat the symptoms of attention deficit hyperactivity disorder (ADHD) is increasing, so does concern about the potential effects of these drugs on the fetuses. A study that was published in the journal Molecular Psychiatry adds to the existing information on this topic. With two massive data sets researchers were able look at more than 4.3 million pregnancies and determine whether the use of stimulant medications increased the risk of birth defects. Although the risk overall remains low, the researchers did find that first-trimester exposure to ADHD medications was associated with a slightly higher rate of specific heart defects, like ventriculo-septal defects (VSD).

The authors of the study found no connection between early use of medication and congenital abnormalities such as facial clefting or club foot. The results are consistent with previous studies showing an increase, but not significant, in the risk of heart malformations among women who began taking ADHD medications prior to the time of pregnancy. The risk increased in the latter stages of pregnancy, when a lot of women stopped taking their medication.

Women who used ADHD medications during the first trimester of their pregnancy were also more likely to undergo caesarean section, low Apgar score following delivery, and a baby that required breathing assistance at birth. However the authors of the study were not able to eliminate bias due to selection by limiting the study to women who didn't have other medical issues that could have contributed to the findings.

The researchers hope their study will aid in the clinical decisions of physicians who encounter pregnant women. They advise that while discussing the risks and benefits is crucial however, the decision to stop or maintain treatment should be based on each woman's needs and the severity of her ADHD symptoms.

The authors also advise that while discontinuing the medications is an option, it is not an option to consider due to the high rate of depression and other mental health problems in women who are pregnant or who are recently postpartum. Additionally, the research suggests that women who choose to stop taking their medication are more likely to have difficulties adapting to life without them after the birth of their baby.

Nursing

It can be overwhelming to become a mom. Women with ADHD who must work through their symptoms while attending doctor appointments as well as making preparations for the arrival of their child and getting used to new routines at home may face a lot of challenges. Therefore, many women elect to continue taking their ADHD medication throughout the pregnancy.

The majority of stimulant drugs are absorbed through breast milk in low amounts, therefore the risk to the nursing infant is very low. However, the amount of exposure to medications prescribed for adhd by the newborn may differ based on dosage, how often it is administered and at what time it is administered. In addition, individual medications enter the body of the baby differently through the gastrointestinal tract as well as breast milk and the impact of this on a newborn infant is not fully understood.

Due to the absence of research, some physicians may be inclined to discontinue stimulant medication during a woman's pregnancy. This is a difficult choice for the patient, who must balance the benefits of continuing her medication against the potential dangers to the embryo. In the meantime, until more information is available, GPs should ask all pregnant patients about their experience with ADHD and if they plan or are taking to take medication during the perinatal period.

Numerous studies have demonstrated that women can continue taking their ADHD medication in a safe manner during pregnancy and while breast-feeding. In response, a growing number of patients are opting to do so. They have found after consulting with their doctors, that the benefits of keeping their current medication outweigh possible risks.

It's important for women with ADHD who are thinking of breastfeeding to seek out a specialist psychiatrist's advice prior becoming pregnant. They should review their medications with their doctor and discuss the pros and cons of continued treatment, including non stimulant adhd medication-pharmacological management strategies. Psychoeducation is also necessary to help pregnant women suffering from ADHD be aware of the symptoms and underlying disorder. They should also be educated about treatment options and reinforce the coping mechanisms. This should be an approach that is multidisciplinary, including the GP, obstetricians and psychiatry. Pregnancy counselling should include the discussion of a plan for management for both the mother as well as the child, as well as monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.